AICDA and B-cell non-Hodgkin lymphoma: PhasED-seq seems particularly useful in B-cell lymphoma, as mutations accumulate in stereotyped genetic regions caused by ongoing SHM and aberrant SHM through the activity of the enzyme activation-induced cytidine deaminase (AID) [49–51].